The first generic version of Forest Laboratories Inc.'s antidepressant Lexapro permitted by Food and Drug Administration, U.S.
An application from Teva Pharmaceutical Industries Ltd. Was allowed by FDA to sell escitalopram, a generic immitator of the oral drug as per Reuters.
Complete rights on the drug are retained by the Forest Labs till March 2012 and Teva has been sued for violation in the court. This copyright is illogical as per Teva.
Lundbeck, a Danish pharmaceutical whose sales in the latest quarter were $464 million accepts royalties of Lexpro sold in U.S.